Things didn’t go easily: The primary rollout was marked by 8 “important” severity defects, 47 substantial-severity defects, and Countless additional issues recorded in the course of an extended duration of “go-live hypercare.” By March 2017 the undertaking had long gone to this point south that MillerCoors sued HCL for $a hundred million,